*Inclusion Criteria*:Written informed consent.
Item
*Inclusion Criteria*:Written informed consent.
boolean
C1512693 (UMLS CUI [1,1])
C0021430 (UMLS CUI [1,2])
Age range of 18 through 40 years old.
Item
Age range of 18 through 40 years old.
boolean
C0001779 (UMLS CUI [1,1])
Subject is in good health.
Item
Subject is in good health.
boolean
C0681850 (UMLS CUI [1,1])
C1277245 (UMLS CUI [1,2])
If subject has any medical conditions, they must be stable - where stable is defined as not requiring either a significant change in therapy or a hospitalization in the last 12 weeks.
Item
If subject has any medical conditions, they must be stable - where stable is defined as not requiring either a significant change in therapy or a hospitalization in the last 12 weeks.
boolean
C1282982 (UMLS CUI [1,1])
C1611645 (UMLS CUI [1,2])
C3665894 (UMLS CUI [1,3])
C0019993 (UMLS CUI [1,4])
Subject has received one and only one dose of smallpox vaccine more than one month ago but within the last 4 years.
Item
Subject has received one and only one dose of smallpox vaccine more than one month ago but within the last 4 years.
boolean
C0205447 (UMLS CUI [1,1])
C0037355 (UMLS CUI [1,2])
C0332168 (UMLS CUI [1,3])
Subject recalls having had a "good take" from the smallpox vaccine leaving a sore or lesion as an expected vaccine reaction that may or may not have left a scar where the vaccine was given.
Item
Subject recalls having had a "good take" from the smallpox vaccine leaving a sore or lesion as an expected vaccine reaction that may or may not have left a scar where the vaccine was given.
boolean
C0025260 (UMLS CUI [1,1])
C0037355 (UMLS CUI [1,2])
C0234233 (UMLS CUI [1,3])
C0221198 (UMLS CUI [1,4])
C0413534 (UMLS CUI [1,5])
C1517001 (UMLS CUI [1,6])
C2004491 (UMLS CUI [1,7])
Subject is able to follow study procedures.
Item
Subject is able to follow study procedures.
boolean
C0681850 (UMLS CUI [1,1])
C1299581 (UMLS CUI [1,2])
C4281991 (UMLS CUI [1,3])
C2348563 (UMLS CUI [1,4])
Subject agrees NOT to donate blood in the next 56 days.
Item
Subject agrees NOT to donate blood in the next 56 days.
boolean
C0680240 (UMLS CUI [1,1])
C1518422 (UMLS CUI [1,2])
C2145403 (UMLS CUI [1,3])
C0332168 (UMLS CUI [1,4])
*Exclusion Criteria*:Subject has donated blood within the last 56 days.
Item
*Exclusion Criteria*:Subject has donated blood within the last 56 days.
boolean
C0680251 (UMLS CUI [1,1])
C2145403 (UMLS CUI [1,2])
C0332168 (UMLS CUI [1,3])
Subject has a known or suspected immunodeficiency or is receiving treatment with immunosuppressive therapy including cytotoxic agents or systemic corticosteroids (e.g. for cancer, HIV, or autoimmune disease.
Item
Subject has a known or suspected immunodeficiency or is receiving treatment with immunosuppressive therapy including cytotoxic agents or systemic corticosteroids (e.g. for cancer, HIV, or autoimmune disease.
boolean
C0681850 (UMLS CUI [1,1])
C0205309 (UMLS CUI [1,2])
C0277540 (UMLS CUI [1,3])
C0021051 (UMLS CUI [1,4])
C0087111 (UMLS CUI [1,5])
C0021079 (UMLS CUI [1,6])
C0304497 (UMLS CUI [1,7])
C3653708 (UMLS CUI [1,8])
C0006826 (UMLS CUI [1,9])
C0019682 (UMLS CUI [1,10])
C0004364 (UMLS CUI [1,11])
Subject has received systemic corticosteroids for treatment of an acute illness in the last 30 days.
Item
Subject has received systemic corticosteroids for treatment of an acute illness in the last 30 days.
boolean
C3653708 (UMLS CUI [1,1])
C0087111 (UMLS CUI [1,2])
C4061114 (UMLS CUI [1,3])
C0332168 (UMLS CUI [1,4])
Subject has a serious chronic disorder including metastatic malignancy, severe chronic obstructive pulmonary disease requiring supplemental oxygen, end stage renal disease with or without dialysis, clinically unstable cardiac disease, or any other disorder that in the investigators opinion precludes the subject from participating in the study.
Item
Subject has a serious chronic disorder including metastatic malignancy, severe chronic obstructive pulmonary disease requiring supplemental oxygen, end stage renal disease with or without dialysis, clinically unstable cardiac disease, or any other disorder that in the investigators opinion precludes the subject from participating in the study.
boolean
C0008679 (UMLS CUI [1,1])
C0205404 (UMLS CUI [1,2])
C4698656 (UMLS CUI [1,3])
C0730607 (UMLS CUI [1,4])
C1514873 (UMLS CUI [1,5])
C4534306 (UMLS CUI [1,6])
C0022661 (UMLS CUI [1,7])
C4551529 (UMLS CUI [1,8])
C0018799 (UMLS CUI [1,9])
C0443343 (UMLS CUI [1,10])
Subject has received any blood products, including immunoglobulin, within 6 months of study enrollment.
Item
Subject has received any blood products, including immunoglobulin, within 6 months of study enrollment.
boolean
C5441444 (UMLS CUI [1,1])
C0332168 (UMLS CUI [1,2])
Subject is excluded if they ever contracted a rash or some other disease as a result of direct exposure to another person's smallpox vaccination reaction.
Item
Subject is excluded if they ever contracted a rash or some other disease as a result of direct exposure to another person's smallpox vaccination reaction.
boolean
C2828389 (UMLS CUI [1,1])
C1140999 (UMLS CUI [1,2])
C0015230 (UMLS CUI [1,3])
C3203558 (UMLS CUI [1,4])
C0413551 (UMLS CUI [1,5])
Subject has any medical condition that would, in the opinion of the investigator, interfere with the evaluation of the study objectives.
Item
Subject has any medical condition that would, in the opinion of the investigator, interfere with the evaluation of the study objectives.
boolean
C0681850 (UMLS CUI [1,1])
C4745084 (UMLS CUI [1,2])
C0521102 (UMLS CUI [1,3])
C0220825 (UMLS CUI [1,4])
C2985627 (UMLS CUI [1,5])
Subject previously participated in this particular study.
Item
Subject previously participated in this particular study.
boolean
C0681850 (UMLS CUI [1,1])
C0205156 (UMLS CUI [1,2])
C0679823 (UMLS CUI [1,3])
C0947630 (UMLS CUI [1,4])